|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 249/12 | |
| C07D 401/04 | |||
| C07D 405/04 | |||
| C07D 403/04 | |||
| A61K 31/4196 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2295416 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10075465.4 |
| Europos patento paraiškos padavimo data | 2005-11-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-03-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-01-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 628979 P | 2004-11-18 | US | |
| 709358 P | 2005-08-18 | US | |
| 725044 P | 2005-10-06 | US |
| (72) |
Ying, Weiwen, US
James, David, US
Zhang, Shijie, US
Przewloka, Teresa, US
Chae, Junghyun, KR
Chimmanamada, Dinesh U, US
Lee, Chi-Wan, US
Kostik, Elena, US
Ng, Howard P., US
Foley, Kevin, US
Du, Zhenjian, US
Barsoum, James, US
|
| (73) |
Synta Pharmaceuticals Corp.,
45 Hartwell Avenue, Lexington, MA 02421,
US
|
| (54) | Triazole compounds that modulate HSP90 activity |
| Triazole compounds that modulate HSP90 activity |